70 companies

Palantir Technologies

Market Cap: US$410.6b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$179.53

7D

0.4%

1Y

361.6%

Aldeyra Therapeutics

Market Cap: US$344.7m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$5.51

7D

5.8%

1Y

4.4%

RenovoRx

Market Cap: US$48.4m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$1.34

7D

13.6%

1Y

25.2%

Vanda Pharmaceuticals

Market Cap: US$320.9m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$5.40

7D

10.0%

1Y

20.0%

OS Therapies

Market Cap: US$63.9m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$2.07

7D

3.0%

1Y

-36.9%

Circle Internet Group

Market Cap: US$33.7b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

CRCL

US$148.51

7D

11.1%

1Y

n/a

Zscaler

Market Cap: US$48.3b

Operates as a cloud security company worldwide.

ZS

US$305.24

7D

2.8%

1Y

77.3%

Workday

Market Cap: US$63.1b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$238.36

7D

-3.8%

1Y

1.2%

Gorilla Technology Group

Market Cap: US$527.8m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

GRRR

US$20.67

7D

6.2%

1Y

406.6%

ACADIA Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$21.59

7D

1.3%

1Y

46.6%

ADMA Biologics

Market Cap: US$3.5b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$14.07

7D

-4.3%

1Y

-30.3%

Cellebrite DI

Market Cap: US$4.6b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

CLBT

US$18.80

7D

-0.9%

1Y

6.3%

Atlassian

Market Cap: US$39.5b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

TEAM

US$150.19

7D

-9.1%

1Y

-10.4%

HubSpot

Market Cap: US$23.8b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

HUBS

US$463.59

7D

-10.8%

1Y

-11.2%

Zeta Global Holdings

Market Cap: US$4.6b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

ZETA

US$19.98

7D

-5.0%

1Y

-34.2%

Reddit

Market Cap: US$38.8b

Operates a digital community in the United States and internationally.

RDDT

US$203.63

7D

-15.8%

1Y

189.1%

Commvault Systems

Market Cap: US$8.0b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

CVLT

US$178.20

7D

-7.7%

1Y

16.7%

Anavex Life Sciences

Market Cap: US$855.5m

Operates as a biopharmaceutical company.

AVXL

US$9.61

7D

11.1%

1Y

79.0%

Cheetah Mobile

Market Cap: US$249.2m

Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.

New

CMCM

US$8.83

7D

7.6%

1Y

57.4%

Krystal Biotech

Market Cap: US$5.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

KRYS

US$180.57

7D

2.2%

1Y

3.2%

Protalix BioTherapeutics

Market Cap: US$193.7m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

PLX

US$2.60

7D

20.4%

1Y

154.9%

Evaxion

Market Cap: US$34.3m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

EVAX

US$6.95

7D

82.9%

1Y

-51.2%

Creative Medical Technology Holdings

Market Cap: US$8.3m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

CELZ

US$3.38

7D

2.1%

1Y

15.8%

Glimpse Group

Market Cap: US$36.7m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

VRAR

US$1.70

7D

-6.1%

1Y

136.1%

Trade Desk

Market Cap: US$25.2b

Operates as a technology company in the United States and internationally.

TTD

US$53.14

7D

7.1%

1Y

-52.5%

MNTN

Market Cap: US$1.3b

Operates a technology platform that brings performance marketing to Connected TV.

MNTN

US$18.16

7D

-2.7%

1Y

n/a

Applied Optoelectronics

Market Cap: US$1.7b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$33.79

7D

30.3%

1Y

126.2%

Aprea Therapeutics

Market Cap: US$8.7m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

APRE

US$1.49

7D

-1.7%

1Y

-43.3%

Arcturus Therapeutics Holdings

Market Cap: US$612.6m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ARCT

US$21.01

7D

11.9%

1Y

-12.0%

GeoVax Labs

Market Cap: US$14.7m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

New

GOVX

US$0.57

7D

-8.6%

1Y

-71.4%

Pure Storage

Market Cap: US$28.6b

Provides data storage and management technologies, products, and services in the United States and internationally.

PSTG

US$90.33

7D

8.9%

1Y

76.0%

Protagonist Therapeutics

Market Cap: US$4.0b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$64.14

7D

-1.5%

1Y

46.4%

Procore Technologies

Market Cap: US$10.9b

Provides a cloud-based construction management platform and related products and services in the United States and internationally.

New

PCOR

US$73.14

7D

-2.3%

1Y

24.4%

KVH Industries

Market Cap: US$107.6m

Engages in the design, development, manufacture, and marketing of mobile connectivity solutions for the marine and land mobile markets in the United States and internationally.

KVHI

US$5.65

7D

0%

1Y

18.9%

CarGurus

Market Cap: US$3.8b

Operates an online automotive platform for buying and selling vehicles in the United States and internationally.

CARG

US$36.24

7D

-3.2%

1Y

24.1%

Exelixis

Market Cap: US$10.8b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$40.01

7D

-1.4%

1Y

52.1%

Page 1 of 2